Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 08:34 am Sale | 2022-12-31 | 13G | Forma Therapeutics Holdings, Inc. FMTX | Deep Track Capital, LP | 0 0.000% | -2,686,655 (Position Closed) | Filing History |
| 2022-10-14 4:03 pm Sale | 2022-10-14 | 13D | Forma Therapeutics Holdings, Inc. FMTX | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -9,040,309 (Position Closed) | Filing History |
| 2022-09-02 4:30 pm Purchase | 2022-08-31 | 13D | Forma Therapeutics Holdings, Inc. FMTX | RA CAPITAL MANAGEMENT L.P. | 9,040,309 18.880% | 11,125 (+0.12%) | Filing History |
| 2022-06-03 4:12 pm Purchase | 2022-05-26 | 13G | Forma Therapeutics Holdings, Inc. FMTX | Deep Track Capital, LP | 2,686,655 5.620% | 2,686,655 (New Position) | Filing History |
| 2022-05-10 10:13 am Sale | 2022-05-09 | 13G | Forma Therapeutics Holdings, Inc. FMTX | FMR LLC | 222,990 0.492% | -3,654,062 (-94.25%) | Filing History |
| 2022-02-14 3:13 pm Purchase | 2021-12-31 | 13G | Forma Therapeutics Holdings, Inc. FMTX | Cormorant Asset Management, LP | 4,639,998 9.790% | 179,998 (+4.04%) | Filing History |
| 2022-02-11 4:31 pm Sale | 2021-12-31 | 13G | Forma Therapeutics Holdings, Inc. FMTX | Novartis Bioventures Ltd | 1,757,057 3.710% | -1,234,648 (-41.27%) | Filing History |
| 2022-02-10 4:29 pm Purchase | 2021-12-31 | 13G | Forma Therapeutics Holdings, Inc. FMTX | ELI LILLY & Co LLY | 339,191 0.700% | 339,191 (New Position) | Filing History |
| 2022-02-10 08:11 am Purchase | 2021-12-31 | 13G | Forma Therapeutics Holdings, Inc. FMTX | The Vanguard Group | 2,860,653 6.030% | 2,860,653 (New Position) | Filing History |
| 2022-02-09 09:19 am Sale | 2022-02-08 | 13G | Forma Therapeutics Holdings, Inc. FMTX | FMR LLC | 3,877,052 8.178% | -873,437 (-18.39%) | Filing History |
| 2022-02-03 4:41 pm Purchase | 2021-12-31 | 13G | Forma Therapeutics Holdings, Inc. FMTX | BlackRock Inc. BLK | 3,026,666 6.400% | 391,916 (+14.87%) | Filing History |
| 2021-10-28 4:32 pm Purchase | 2009-02-28 | 13D | Forma Therapeutics Holdings, Inc. FMTX | RA CAPITAL MANAGEMENT L.P. | 9,029,184 19.050% | 17,533 (+0.19%) | Filing History |